Contract notice
Section I: Contracting
authority
I.1) Name and addresses
NHS Kent and Medway Integrated Care Board
2nd floor Gail House Lower Stone Street
Maidstone
ME15 6NB
UK
E-mail: l.gamlin@nhs.net
NUTS: UKJ41
Internet address(es)
Main address: https://www.kentandmedway.icb.nhs.uk/
Address of the buyer profile: https://www.kentandmedway.icb.nhs.uk/
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://health-family.force.com/s/Welcome
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://health-family.force.com/s/Welcome
Tenders or requests to participate must be sent to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://health-family.force.com/s/Welcome
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
K&M Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long Covid
Reference number: C404354
II.1.2) Main CPV code
85100000
II.1.3) Type of contract
Services
II.1.4) Short description
NHS Kent & Medway Integrated Care Board are undertaking a Provider Selection Regime (PSR) Competitive Process and are inviting suitably qualified and experienced providers to bid for a Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long Covid Service in Kent and Medway. The contract duration will be for an initial period of 3 years with an option to extend for up to a further 2 years as required.
II.1.5) Estimated total value
Value excluding VAT:
9 500 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.2) Additional CPV code(s)
85100000
II.2.3) Place of performance
NUTS code:
UKJ4
II.2.4) Description of the procurement
NHS Kent & Medway Integrated Care Board are undertaking a Provider Selection Regime (PSR) Competitive Process and are inviting suitably qualified and experienced providers to bid for a Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long Covid Service in Kent and Medway. The contract duration will be for an initial period of 3 years with an option to extend for up to a further 2 years as required.<br/><br/>To provide an integrated specialist service for adults (and transitioning young people) with suspected or diagnosed ME/CFS and/or Long Covid across Kent and Medway.<br/><br/>Key Features of the Service:<br/>• Early diagnosis and personalised care planning<br/>• Multidisciplinary team (MDT) approach including medical, nursing, AHPs, and care coordinators<br/>• Virtual and in-person support options<br/>• Integration with primary care, community services, and voluntary sector<br/>• Support for self-management, rehabilitation, and return to work/education<br/>• Dedicated pathways for severely affected patients, including home-based care<br/>• Transition support for young people moving from paediatric to adult services<br/><br/>To provide full end to end pathway for patients with Long Covid & Chronic Fatigue. It includes diagnostics, treatment, rehabilitation and recovery support and delivery of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long Covid to meet the clinic specification in the recently revised national guide for post-COVID syndrome assessment clinics. To support serious debilitating conditions that can follow any type of viral infection. Both conditions have key symptoms in common and there may be similar level of functional impairment in in both. However, there are some important differences that distinguish some people with Long Covid from those with ME/CFS.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
9 500 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 60
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
Yes
Description of options:
Contract may be extended by up to 2 years
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
05/02/2026
Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 4 (from the date stated for receipt of tender)
IV.2.7) Conditions for opening of tenders
Date:
05/02/2026
Local time: 12:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.3) Additional information
To access the eProcurement portal to access relevant documentation relating this<br/>opportunity, please follow the instructions below:<br/>1. Go to https://health-family.force.com/s/Welcome (and click the link to register (If your<br/>organisation has not registered previously)<br/>2. Once registered, login into the system and look for 'Quote/tender C404354 K&M Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long Covid'<br/>This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is<br/>subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the<br/>avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award.
VI.4) Procedures for review
VI.4.1) Review body
NHS England
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
UK
E-mail: england.commercialqueries@nhs.net
Internet address(es)
URL: https://www.england.nhs.uk/
VI.5) Date of dispatch of this notice
05/01/2026